Apelin Levels and G212A Polymorphism of Apelin Receptor (APJ)
Serum Apelin Levels and G212A Polymorphism of Apelin Receptor (APJ)in Obese Children and Adolescents.
1 other identifier
observational
180
1 country
1
Brief Summary
The aim of this study is to investigate serum apelin levels as well as their possible association with G212A polymorphism of the apelin receptor in obese children and adolescents. So far apelin has been reported to be involved in the pathophysiology of various heart diseases such as cardiomyopathies and heart failure. According to recent reports in adults apelin seems to be associated with impaired glucose metabolism, particularly in newly diagnosed diabetes type 2 patients. Obesity is associated with insulin resistance and compensatory hyperinsulinemia leading to diabetes mellitus type 2 even in youngsters. The researchers will try to investigate the role of this new adipokine in order to early detect and to prevent similar entities in childhood obesity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2010
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2010
CompletedFirst Submitted
Initial submission to the registry
May 4, 2010
CompletedFirst Posted
Study publicly available on registry
May 12, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2014
CompletedResults Posted
Study results publicly available
May 19, 2016
CompletedMay 19, 2016
April 1, 2016
2.1 years
May 4, 2010
March 15, 2016
April 13, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Serum Apelin Levels
Apelin levels were measured in serum of participants, in fasting state
First day after enrollment and after 8-hours of night fasting, at approximately 8:00 pm in the morning
Secondary Outcomes (1)
Frequency of G212A Polymorphism of Apelin Receptor in Obese Children and Adolescents
First day after enrollment
Study Arms (2)
obese
obese subjects according to International Obesity Task Force criteria
lean
Eligibility Criteria
40 obese children 40 obese adolescents 50 lean children 50 lean adolescents
You may qualify if:
- Obese children and adolescents (aged 2-16 years old)
You may not qualify if:
- Chronic diseases
- Hypothyroidism
- Medication
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Unit of Pediatric Endocrinology, Diabetes and Metabolism-4th Department of Pediatrics, Medical School of Aristotle University of Thessaloniki
Thessaloniki, 56403, Greece
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Assimina Galli-Tsinopoulou, As.Professor of Pediatric Endocrinology
- Organization
- 4th Department of Pediatrics, School of Medicine, Aristotle University of Thessaloniki
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- As. Professor in Pediatric Endocrinology
Study Record Dates
First Submitted
May 4, 2010
First Posted
May 12, 2010
Study Start
May 1, 2010
Primary Completion
June 1, 2012
Study Completion
January 1, 2014
Last Updated
May 19, 2016
Results First Posted
May 19, 2016
Record last verified: 2016-04